Shares of Transenterix Inc (NASDAQ:TRXC) saw unusually-strong trading volume on Monday . Approximately 80,347,451 shares traded hands during mid-day trading, an increase of 6,105% from the previous session’s volume of 1,294,830 shares.The stock last traded at $2.81 and had previously closed at $1.46.
Separately, Zacks Investment Research raised shares of Transenterix from a “hold” rating to a “buy” rating and set a $0.75 price objective on the stock in a research note on Thursday, July 13th.
The company’s 50 day moving average price is $1.28 and its 200-day moving average price is $0.87. The stock’s market cap is $417.39 million.
Several institutional investors have recently modified their holdings of the company. Sabby Management LLC bought a new position in shares of Transenterix in the second quarter worth approximately $2,456,000. Goldman Sachs Group Inc. grew its holdings in shares of Transenterix by 7,137.7% in the second quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock worth $854,000 after purchasing an additional 1,186,575 shares during the last quarter. UBS Oconnor LLC bought a new position in shares of Transenterix in the second quarter worth approximately $390,000. Royal Bank of Canada grew its holdings in shares of Transenterix by 17.1% in the second quarter. Royal Bank of Canada now owns 418,867 shares of the company’s stock worth $298,000 after purchasing an additional 61,034 shares during the last quarter. Finally, Global X Management Co. LLC grew its holdings in shares of Transenterix by 238.3% in the second quarter. Global X Management Co. LLC now owns 331,075 shares of the company’s stock worth $235,000 after purchasing an additional 233,213 shares during the last quarter.
COPYRIGHT VIOLATION WARNING: “Transenterix Inc (TRXC) Sees Large Volume Increase” was originally posted by Markets Daily and is the property of of Markets Daily. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://www.themarketsdaily.com/2017/10/17/transenterix-inc-trxc-sees-large-volume-increase.html.
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with MarketBeat.com's FREE daily email newsletter.